Search

everythinglearnresearchcommunity

for

Search:↓

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Densitometry and video-microscopy are precise for evaluating hair loss and transplant success but need special equipment and training.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

The MDhair app accurately assesses hair loss severity with 94% accuracy.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Trichoscopy helps diagnose and monitor hair and scalp problems without needing many biopsies.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Kids with vitiligo, psoriasis, or alopecia areata are more likely to experience anxiety, depression, and social challenges.

Chronic scarring alopecia is common in SLE patients and needs early detection and management.

Family history affects hair loss severity and onset more in men than women.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

The treatment with Bakuchiol and Neem oil significantly improved hair growth and was well-received by most participants.

Scalp disease in dermatomyositis causes significant symptoms and has unique features.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

A comprehensive scoring system for alopecia areata severity is needed.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Baricitinib is effective and safe for treating severe alopecia areata.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

Oral baricitinib is effective and safe for treating alopecia areata.

Guidelines help design better trials to compare alopecia areata treatments.

Hair thickness differences help diagnose hair loss severity.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.